Prealize Funding: How Much Did They Raise & Key Investors

How Much Did Prealize Raise?
Funding & Key Investors

Prealize has successfully secured a total of $30.9M in capital to accelerate its mission of transforming the healthcare landscape through advanced artificial intelligence. This trajectory of financial backing, which includes a recent strategic investment of $22M, underscores the market's growing confidence in the company's ability to mitigate clinical risks before they escalate. By leveraging sophisticated predictive modeling, the firm has positioned itself as a critical partner for organizations seeking to optimize patient outcomes and operational efficiency.

The company's growth story began with early-stage financing in 2017, followed by a significant Series B round in 2019. This progression highlights a clear transition from initial product development to a robust enterprise-level scaling phase, enabling the platform to integrate deeper into the complex infrastructure of modern health systems.

What is Prealize?

Prealize

Software

Healthcare Software

Headquartered in Palo Alto, California, Prealize operates at the intersection of data science and clinical care. The platform utilizes proprietary AI-enabled technology to identify and manage future health risks, effectively shifting the industry paradigm from reactive treatment to proactive health management. By synthesizing vast datasets, Prealize provides actionable intelligence that allows healthcare providers and payers to intervene early, thereby reducing long-term costs and improving the quality of life for patient populations. Its market position is defined by its ability to translate complex health data into meaningful, real-time clinical insights.

How much funding has Prealize raised?

Prealize has raised a total of $30.9M across 3 funding rounds:

2017

Private Equity

$2.8M

Series A

$6.1M

2019

Series B

$22M

Private Equity (2017): $2.8M, investors not publicly disclosed

Series A (2017): $6.1M led by Stanford StartX, Cardinal Partners, and Premera Blue Cross

Series B (2019): $22M, investors not publicly disclosed

Key Investors in Prealize

Stanford StartX

A non-profit accelerator and community for Stanford-affiliated entrepreneurs, providing resources and mentorship to high-growth startups.

Cardinal Partners

A venture capital firm focused on early-stage investments in the healthcare and life sciences sectors.

Premera Blue Cross

A leading health insurance provider that invests in innovative technologies to improve member health outcomes and operational efficiency.

What's next for Prealize?

With the infusion of capital from its latest financing round, Prealize is well-positioned to expand its footprint within the enterprise health sector. The strategic focus will likely center on scaling its predictive analytics engine to accommodate larger datasets and more diverse clinical environments. As the healthcare industry continues to prioritize value-based care, Prealize's capacity to forecast health trajectories will be instrumental in driving systemic change. Future initiatives will likely involve deepening partnerships with major health plans and provider networks to solidify its role as an essential component of the digital health ecosystem.

See full Prealize company page

See More Financial Insights